Prelude Therapeutics Stock Forecast

Buy or Hold candidate since Jul 28, 2026 Loss -0.86%

The Prelude Therapeutics Incorporated stock price fell by -8.91% on the last day (Friday, 31st Jul 2026) from $5.05 to $4.60. During the last trading day the stock fluctuated 10.83% from a day low at $4.57 to a day high of $5.07. The price has been going up and down for this period, and there has been a 9.52% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -45 thousand shares and in total, 285 thousand shares were bought and sold for approximately $1.31 million.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Prelude Therapeutics Incorporated stock with a 90% probability to be traded between $3.50 and $5.33 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

PRLD Signals & Forecast

The Prelude Therapeutics Incorporated stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $4.38 and $4.47. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, July 30, 2026, and so far it has fallen -8.91%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Prelude Therapeutics Incorporated stock

Prelude Therapeutics Incorporated finds support from accumulated volume at $4.38 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.495 between high and low, or 10.83%. For the last week the stock has had daily average volatility of 10.87%.

Our recommended stop-loss: $4.33 (-5.94%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (PRLD) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Prelude Therapeutics Incorporated to open at $4.75, and during the day (based on 14 day Average True Range), to move between $4.40 and $4.80, which gives a possible trading interval of +/-$0.392 (+/-8.91%) up or down from last closing price. If Prelude Therapeutics Incorporated takes out the full calculated possible swing range there will be an estimated 8.91% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $4.64 (0.87%) than the support at $4.38 (4.78%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Prelude Therapeutics Incorporated stock A Buy?

Prelude Therapeutics Incorporated holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

Current score: 0.281 Hold/Accumulate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $4.75 ( 3.15%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk